Oxidative stress as a possible pathogenic cofactor of post-menopausal osteoporosis: Existing evidence in support of the axis oestrogen deficiency-redox imbalance-bone loss

Indian J Med Res. 2018 Apr;147(4):341-351. doi: 10.4103/ijmr.IJMR_524_18.

Abstract

Post-menopausal osteoporosis (PO) is one of the major health issues associated with menopause-related oestrogen withdrawal. Despite the intense research and the relevant progress achieved in the last two decades, the pathogenic mechanism underlying PO is still poorly understood. As a consequence of this gap in the knowledge, such disorder and the related complications are still difficult to be effectively prevented. A wealth of experimental and epidemiological/clinical evidence suggests that the endocrine change associated to menopausal transition might lead to a derangement of redox homeostasis, that is, the prelude to the health-threaten condition of oxidative stress (OxS). In turn, this (bio)chemical stress has been widely hypothesized to contribute, most likely in synergy with inflammation, to the development of menopause-related diseases, including PO. The main aim of this review is to discuss the current literature evidence on the association between post-menopausal oestrogen withdrawal, OxS and PO. It is also aimed to provide a critical overview of the most significant epidemiological studies on the effects of dietary antioxidants on bone health and to devise a strategy to overcome the limitations emerged and controversial results.

Keywords: Menopause - oestrogens - oxidative stress - post-menopausal osteoporosis - reactive oxygen species - redox homeostasis.

Publication types

  • Review

MeSH terms

  • Aged
  • Estrogens
  • Female
  • Humans
  • Menopause
  • Osteoporosis, Postmenopausal / physiopathology*
  • Oxidation-Reduction
  • Oxidative Stress*

Substances

  • Estrogens